Chemours (CC) PT Lowered to $39 at BMO Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- US stocks set for higher open as AI trade steadies; midterms in focus
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 6% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts CC Hot Sheet
Price: $13.57 +0.30%
Rating Summary:
7 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 16
Rating Summary:
7 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 16
Join SI Premium – FREE
BMO Capital analyst John McNulty lowered the price target on Chemours (NYSE: CC) to $39.00 (from $45.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Hartford Financial Services (HIG) PT Lowered to $136 at Cantor Fitzgerald
- Gates Industrial Corp. (GTES) PT Lowered to $27 at DA Davidson
- Pinterest Inc (PINS) PT Lowered to $25 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
